Differences in Performance on English and Hebrew Versions of the MoCA in Parkinson's Patients
Overview
Authors
Affiliations
Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable.
Methods: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language.
Results: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRSIII), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, = 0.111).
Conclusion: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation.
Hsu J, Liu C, Chen I, Wu J, Huang P, Liu T Front Public Health. 2023; 11:1293710.
PMID: 38026272 PMC: 10644725. DOI: 10.3389/fpubh.2023.1293710.
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.
Debroff J, Omer N, Cohen B, Giladi N, Kestenbaum M, Shirvan J Mov Disord Clin Pract. 2023; 10(4):606-616.
PMID: 37070047 PMC: 10105114. DOI: 10.1002/mdc3.13722.
Saunders-Pullman R, Ortega R, Wang C, Raymond D, Elango S, Leaver K Neurology. 2022; 99(8):e814-e823.
PMID: 35995594 PMC: 9484727. DOI: 10.1212/WNL.0000000000200737.
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
Ortega R, Wang C, Raymond D, Bryant N, Scherzer C, Thaler A JAMA Netw Open. 2021; 4(4):e215845.
PMID: 33881531 PMC: 8060834. DOI: 10.1001/jamanetworkopen.2021.5845.
Rosenblum S, Meyer S, Gemerman N, Mentzer L, Richardson A, Israeli-Korn S Mov Disord Clin Pract. 2020; 7(6):648-655.
PMID: 32775510 PMC: 7396845. DOI: 10.1002/mdc3.12969.